Phage therapy against Achromobacter xylosoxidans lung infection in a patient with cystic fibrosis: a case report

Research in Microbiology
N HoyleM Kutateladze

Abstract

Respiratory infections can lead to serious complications in CF patients, especially when infected with antibiotic resistant bacteria. Alternative treatments for these infections are being sought out to help address this problem. We present a clinical case of a cystic fibrosis (CF) patient, with multi-drug resistant (MDR) Achromobacter xylosoxidans chronic lung infection who was successfully managed with bacteriophage therapy.

Citations

Sep 27, 2018·Surgical Infections·Christine RohdeElizabeth Kutter
Mar 1, 2019·Medical Mycology·Wendy W J van de Sande, Alieke G Vonk
Apr 25, 2019·Viruses·Shawna McCallinBenjamin K Chan
Jan 11, 2019·Microbiology and Molecular Biology Reviews : MMBR·Aislinn D Rowan-NashPeter Belenky
Mar 27, 2019·Viruses·Sandra-Maria WienholdMartin Witzenrath
May 30, 2019·Frontiers in Pharmacology·Nicola PrincipiSusanna Esposito
May 31, 2019·Reviews in Medical Virology·Rizka O A Jariah, Mohamad S Hakim
May 30, 2020·International Journal of Molecular Sciences·Alessia BrixAnna Pistocchi
Dec 14, 2018·Frontiers in Pharmacology·Stephanie TrendUNKNOWN AREST CF
Jul 7, 2020·PHAGE : Therapy, Applications, and Research·Elizabeth B BurgenerPaul L Bollyky
May 31, 2020·FEMS Microbiology Reviews·Diana P PiresJoana Azeredo
Aug 21, 2020·Antimicrobial Agents and Chemotherapy·Burcu IslerDavid L Paterson
Dec 1, 2020·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Yu LinHak-Kim Chan
Feb 27, 2021·Frontiers in Microbiology·Nannan Wu, Tongyu Zhu
Jun 18, 2021·Microbial Ecology·Aparna NairKrishna Khairnar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Related Papers

Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
Christine Rønne HansenMagdalena Gormsen
Singapore Medical Journal
S D Puthucheary, Y F Ngeow
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
F De BaetsMario Vaneechoutte
Revista chilena de infectología : órgano oficial de la Sociedad Chilena de Infectología
Andrea Sakurad
© 2022 Meta ULC. All rights reserved